scholarly journals Hypercholesterolemia and the Progression of the Renal Dysfunction in Chronic Renal Failure Patients

1996 ◽  
Vol 6 (4) ◽  
pp. 172-177 ◽  
Author(s):  
Masakazu Washio ◽  
Seiya Okuda ◽  
Masato Ikeda ◽  
Hideki Hirakata ◽  
Fumio Nanishi ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Renal Dysfunction

Renal dysfunction due to advance pelvic organ prolapse

2021 ◽  
Vol 71 (11) ◽  
pp. 2662-2664
Author(s):  
Lubna Razzak ◽  
Sherjeel Saulat
Keyword(s):  
Renal Failure ◽  
Urinary Tract Infection ◽  
Renal Function ◽  
Urinary Tract ◽  
Chronic Renal Failure ◽  
Pelvic Organ Prolapse ◽  
Renal Dysfunction ◽  
Pelvic Organ ◽  
Uterovaginal Prolapse ◽  
Irreversible Damage

Uterovaginal prolapse is the downward descent of the pelvic organ, resulting in protrusion of the vagina, uterus, bladder or rectum. The association between POP and hydronephrosis has been shown by various studies, but severe hydronephrosis leads to renal dysfunction are rarely seen. We report a case of 70 years old female with massive vaginal prolapse and chronic renal impairement. She presented with urinary tract infection (UTI) and raised creatinine levels of 4.5mg/dl. After correction of UTI, she surgically managed to relieve her obstructive symptoms. After surgery her creatinine levels drop to 2.0mg/dl but chronic renal failure persisted. Advance stage prolapsed may damage renal function if left untreated. Timely diagnosis and management may prevent irreversible damage to kidneys Continuous...

Positive correlations between cerebral choline and renal dysfunction in chronic renal failure

2006 ◽  
Vol 48 (5) ◽  
pp. 300-306 ◽  
Author(s):  
Osamu Sasaki ◽  
Noriaki Hattori ◽  
Hajime Nakahama ◽  
Noriko Inoue ◽  
Satoko Nakamura ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Renal Dysfunction ◽  
Positive Correlations

scholarly journals Blood pressure changes during daytime sleep and comparison of daytime and nighttime sleep-related blood pressure changes in patients with chronic renal failure.

1993 ◽  
Vol 4 (5) ◽  
pp. 1172-1177
Author(s):  
S J Rosansky ◽  
K L Johnson ◽  
C Hutchinson ◽  
S Erdel
Keyword(s):  
Blood Pressure ◽  
Heart Rate ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Renal Dysfunction ◽  
Recumbent Position ◽  
Daytime Sleep ◽  
Percent Change ◽  
Pressure Changes ◽  
Nighttime Sleep

Blood pressure has a diurnal pattern primarily related to activity and sleep. Chronic renal failure patients may lack the normal nocturnal decline in blood pressure during sleep. In 33 subjects (14 with normal renal function and 19 with renal dysfunction), the relationship between depth of daytime sleep, as determined by electroencephalographic sleep phase, and change in mean arterial blood pressure (MAP) and heart rate measured oscillometrically, was correlated. In 15 chronic renal failure patients, the effect of daytime and nighttime sleep on MAP and heart rate was compared. The percent change in night asleep versus day awake MAP and heart rate was measured (with Space Labs ambulatory blood pressure monitors) and compared with the percent change in daytime sleep-related MAP and heart rate measured during a daytime sleep electroencephalographic study. During daytime sleep, MAP changes are not significantly different in the normal versus renal dysfunction groups. In the 33 study subjects, MAP declines progressively from the upright position to Phase 3/4 sleep (118 +/- 3.6 to 106 +/- 3.6 mm Hg). The largest decline occurs between the upright to recumbent position, before sleep. Heart rate declines moving from the upright to recumbent position, 76 +/- 2.3 to 70 +/- 2.1 beats/min, but does not decline further with sleep. In 15 chronic renal failure patients, heart rate (10.8 +/- 2.8%; P < 0.05), but not MAP, declines during nighttime sleep. Both MAP (7.7 +/- 3.3%) and heart rate (5.4 +/- 1.9%) decline significantly during daytime sleep. The responses of MAP and heart rate to daytime and nighttime sleep were in opposite directions in 3 of 15 subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Incidence and oncologic outcome of renal cell carcinoma in hemodialysis patients detected by annual computed tomography (CT) screening.

2012 ◽  
Vol 30 (5_suppl) ◽  
pp. 426-426
Author(s):  
Shingo Hatakeyama ◽  
Hayato Yamamoto ◽  
Takahiro Yoneyama ◽  
Yasuhiro Hashimoto ◽  
Takuya Koie ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Renal Dysfunction ◽  
Hemodialysis Patients ◽  
Maintenance Hemodialysis ◽  
Normal Kidney ◽  
Cancer Specific Survival ◽  
Annual Screening ◽  
Function Group

426 Background: Patients with maintenance hemodialysis (HD) have been recognized as a high risk group for cancer. The aim of this study was to verify the incidence and oncological outcomes of patients on maintenance hemodialysis with renal cell carcinoma (RCC) compared with RCC patients without renal dysfunction. Methods: We have been carried out annual screening for renal mass for the hemodialysis patients.The oncological outcome of pT1N0M0 RCC detected by annual screening of CT imaging were retrospectively reviewed in 1217 patients with HD between January 2002 and December 2010 at Oyokyo kidney Research Institute and Hirosaki University Hospital, Hirosaki, Japan. Overall and cancer specific survival was compared with age matched 106 of pT1N0M0 RCC patients without renal dysfunction who performed radical nephrectomy at the same periods. Results: Among the hemodialysis patients, 14 RCCs were incidentally detected by screening CT examinations and RCC detection rate in HD patients was 0.27% per year. Total 119 pT1N0M0 RCC patients (13 with HD group, 106 normal kidney function group) were incidentally detected by regular abdominal CT imaging without symptoms. There were no significant differences on age and gender between HD and normal kidney function group. Cancer specific survival after tumor diagnosis was not different, but overall survivals were significantly superior in patients without renal dysfunction compared to those with chronic renal failure (P < 0.0001). Cancer specific and Overall 5-year survival was 95% and 96% in patients without renal dysfunction, 92% and 54% in those with chronic renal failure. Conclusions: There was no significant difference in cancer specific survival of pT1 RCC between the two groups. However, overall survival was significantly worse in HD patients. Oncological effectiveness of annual CT screening for the HD patients was not evident in the present retrospective study.

scholarly journals Positive correlations between cerebral choline and renal dysfunction in chronic renal failure

2006 ◽  
Vol 48 (7) ◽  
pp. 508-508
Author(s):  
Osamu Sasaki ◽  
Noriaki Hattori ◽  
Hajime Nakahama ◽  
Noriko Inoue ◽  
Satoko Nakamura ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Renal Dysfunction ◽  
Positive Correlations

scholarly journals Cardiac Troponins in Patients with Renal Dysfunction

1998 ◽  
Vol 35 (3) ◽  
pp. 380-386 ◽  
Author(s):  
P O Collinson ◽  
L Hadcocks ◽  
Y Foo ◽  
S B Rosalki ◽  
P J Stubbs ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Detection Limit ◽  
Renal Dysfunction ◽  
Cardiac Troponin ◽  
Troponin I ◽  
Troponin T ◽  
Multiple Organ ◽  
Chronic Renal Impairment ◽  
Cardiac Troponins

Cardiac troponin T (cTnT) and cardiac troponin I (cTnI) were measured in 198 patients with renal dysfunction [132 men: median (range) age 66·1 (8·2-90·3) years]. cTnT was measured by two methods: ELISA and Enzymun (Boehringer Mannheim UK, Lewes, UK), both with a detection limit of 0·05 μg/L in 179 and 78 patients, respectively. cTnI was measured in 80 patients by the OPUS plus and OPUS Magnum systems (Dade-Behring, Milton Keynes, UK) with a detection limit of 0·5 μg/L. Patients were classified as having chronic renal impairment (CRI), chronic renal failure (CRF), acute renal failure including those with multiple organ failure on renal replacement therapy (ARF), and patients with chronic renal failure treated with haemodialysis (HD). Cardiac troponins were detectable in the serum of patients with renal dysfunction. cTnT was detectable in 113/179 (63·1%) and 33/78 (42·3%) by the ELISA and Enzymun methods respectively. cTnI was detectable in 17/80 (21·3%). cTnT (ELISA and Enzymun methods) and cTnI were detectable with increased frequency in the CRF, HD and ARF patient groups compared with the CRI group. Cardiac troponin concentrations did not correlate with serum creatine kinase (CK) activity, CK-MB, or urea or creatinine levels. Serial cardiac troponin measurements may be required to confirm or exclude a diagnosis of acute coronary syndromes in patients with renal dysfunction.

HIV: renal disorders

2019 ◽  
pp. 581-588
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Renal Dysfunction ◽  
Direct Effect ◽  
Renal Disorders ◽  
Failure Assessment ◽  
Drug Doses

This chapter provides an overview of renal problems seen in patients who live with HIV. It outlines the causes of renal dysfunction, including acute and chronic renal failure. Assessment of a patient presenting with renal failure is discussed. The direct effect of HIV on the kidney is discussed. The effect of drugs on the kidneys and the need to modify drug doses are discussed.

Sign in / Sign up

Export Citation Format

Share Document